Literature DB >> 29454570

Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis.

Sivesh K Kamarajah1.   

Abstract

BACKGROUND/
OBJECTIVES: Surgical extirpation for hepatocellular carcinoma (HCC) with background fibrosis remains a challenge. This study evaluated impact of fibrosis score on long term outcomes of patients undergoing surgical resection for HCC.
METHODS: Using the Surveillance, Epidemiology and End Results (SEER) database (2004-2013), complete data on 1433 patients undergoing surgical resection for non-metastatic HCC were identified. Overall survival (OS) was estimated using the Kaplan-Meier method. Cox proportional hazards model were used to produce adjusted hazard ratios (HR).
RESULTS: In this study, 54% (650/1433) patients had F5-6 fibrosis at the time for surgical resection of HCC. In adjusted models, F5/6 fibrosis significantly reduces overall survival (HR: 1.62, 95% CI: 1.34-1.94; p < 0.001). Median survival was significantly longer for patients with F0-4 fibrosis for T1a, T1b and T2 tumours as compared to F5-6 fibrosis, not for T3 and T4 tumours, even when stratified by extent of hepatectomy. There were no significant differences in 90-day post-operative mortality between fibrosis groups when stratified by T-classifications.
CONCLUSION: Liver resection in patients with advanced fibrosis has significantly lower survival as compared to patients with F0-4 fibrosis in early stage (T1 and T2), not advanced tumours (T3 and T4). Improvement in patient selection and perioperative care for liver resection may offer consistent and clinically meaningful long-term survival in HCC.
Copyright © 2018. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  HCC; fibrosis; liver; outcomes; resection

Mesh:

Year:  2018        PMID: 29454570     DOI: 10.1016/j.asjsur.2018.01.001

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  5 in total

1.  Preoperative Alpha-Fetoprotein Has No Prognostic Role in Small Hepatocellular Carcinoma in Non-Cirrhotic Patients After Surgical Resection.

Authors:  Tian-Ming Gao; Dou-Sheng Bai; Jian-Jun Qian; Ping Chen; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

2.  Differences in the safety line of the future liver remnant plasma clearance rate of indocyanine green necessary to prevent post-hepatectomy liver failure associated with underlying diseases.

Authors:  Nobuhito Nitta; Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2021-05-29       Impact factor: 2.549

3.  Is water-soluble contrast enema examination for integrity of rectal anastomosis necessary prior to ileostomy reversal?

Authors:  Hui Lu Goh; Lauren Hawkins; Sivesh K Kamarajah; Sharad Karandikar; Mark Goldstein
Journal:  JGH Open       Date:  2019-11-06

4.  Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.

Authors:  Jian Xi Zhang; Peipei Li; Zhibin Chen; Huogui Lin; Zhezhen Cai; Weijia Liao; Zirong Pan
Journal:  BMC Cancer       Date:  2020-06-15       Impact factor: 4.430

5.  A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy.

Authors:  Bai Wei; Jing-San Chen; Sheng-Li Yang; George G Chen; Hao He
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.